Tumour necrosis factor (TNF) inhibitor-induced isolated pleural granulomas: a rare adverse effect. uri icon

Overview

abstract

  • A 53-year-old man with a history of Crohn's disease on infliximab, presented with several weeks of cough and dyspnoea. He had a right-sided pleural effusion, found to be exudative with lymphocytic predominance. He underwent right-sided video-assisted thoracic surgery (VATS) with biopsies and pleurodesis. Histopathology showed pleural-based non-caseating granulomas with unremarkable lung parenchyma. Cultures were only positive for Propionibacterium acnes 8 months later, he was found to have a left-sided exudative, lymphocytic predominant pleural effusion. Left-sided VATS and biopsies again showed pleural-based non-caseating granulomas with normal lung parenchyma. Having ruled out an active infection and malignant lesions, we diagnosed infliximab-induced pleural granulomas. Infliximab was stopped. The patient continues to do well at 6 years of follow-up. We believe this is the first report of tumour necrosis factor (TNF) inhibitor-induced isolated pleural granulomas. P. acnes and cytokine imbalance might be responsible for the pathogenesis of TNF inhibitor-induced granulomas.

publication date

  • June 18, 2017

Research

keywords

  • Crohn Disease
  • Gastrointestinal Agents
  • Gram-Positive Bacterial Infections
  • Granuloma
  • Infliximab
  • Pleural Effusion
  • Tumor Necrosis Factor-alpha

Identity

PubMed Central ID

  • PMC5534705

Scopus Document Identifier

  • 85020923415

Digital Object Identifier (DOI)

  • 10.1136/bcr-2017-219883

PubMed ID

  • 28630242

Additional Document Info

volume

  • 2017